GEODE CAPITAL MANAGEMENT, LLC - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 30 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 2.31 and the average weighting 0.5%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,548,554
-10.9%
206,199
+4.7%
0.00%
Q2 2023$1,738,423
+971.1%
196,877
+909.3%
0.00%
Q1 2023$162,298
+86690.4%
19,5070.0%0.00%
Q4 2022$187
-99.9%
19,5070.0%0.00%
Q3 2022$158,000
+43.6%
19,5070.0%0.00%
Q2 2022$110,000
+0.9%
19,5070.0%0.00%
Q1 2022$109,000
+26.7%
19,507
-0.6%
0.00%
Q4 2021$86,000
-54.0%
19,619
-1.5%
0.00%
Q3 2021$187,000
+43.8%
19,909
+11.1%
0.00%
Q2 2021$130,000
-87.6%
17,926
-89.4%
0.00%
Q1 2021$1,051,000
-15.9%
169,356
+0.9%
0.00%
Q4 2020$1,250,000
+32.4%
167,843
+7.7%
0.00%
Q3 2020$944,000
-24.7%
155,787
+3.7%
0.00%
Q2 2020$1,254,000
+462.3%
150,200
+226.1%
0.00%
Q1 2019$223,000
-55.6%
46,059
-41.7%
0.00%
Q4 2018$502,000
+79.9%
78,978
+132.0%
0.00%
Q3 2018$279,000
-8.5%
34,048
+16.4%
0.00%
Q2 2018$305,00029,2490.00%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 2,433,230$18,128,0008.76%
Solas Capital Management, LLC 800,000$5,960,0004.55%
Southpoint Capital Advisors LP 4,077,214$30,375,0000.53%
683 Capital Management, LLC 1,110,000$8,269,0000.39%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 40,000$298,0000.26%
Avoro Capital Advisors LLC 1,670,000$12,442,0000.21%
Eventide Asset Management 1,120,000$8,344,0000.13%
Hartford Financial Management Inc. 38,848$289,0000.08%
Granahan Investment Management 394,810$2,941,0000.07%
Planned Solutions, Inc. 800$6,0000.01%
View complete list of FENNEC PHARMACEUTICALS INC shareholders